Suhad Abbas Jasim, Walaa Abdulameer Mahdi, and Bushra Hashim Hameed
Vol. 10, Jul-Dec 2020
Abstract:
This research is aiming to a comparison of how administration of misoprostol via vaginal route is efficient and safe versus intravenous oxytocin infusion for induction of delivery in cases with (PROM) at date. Results show that Misoprostol group showed significantly higher mean induction delivery interval than that of oxytocin group. No significantly different results between the both groups regarding the mode of delivery. No significantly different results between the both groups regarding the neonatal admission to (N.I.C.U). No significantly different results between the both groups regarding the mean of Apgar score at 60 seconds and five minutes. No significantly different results between the both groups regarding uterine hyperstimulation. No significantly different results between the both groups regarding postpartum hemorrhage. No significantly different results between the both groups regarding CS indication. No significantly different results between the both groups regarding emergency CS rate due to distress of the fetus. It is concluded that usage of both IV oxytocin infusion with a rate of 2 mU/min which increased by 2 mU/min each twenty minutes up to a rate of 30 mU/min & misoprostol in the vagina 50 µg intravaginally at six hrs. intervals but not exceeding four dosages for safe delivery induction with PROM. It is preferable to use IV oxytocin if the time factor is considered.